For the quarter ending 2025-12-31.
| Income Statement | 2025-12-31 | 2025-09-30 | ||
|---|---|---|---|---|
| Research and development expenses | 57,147 | 113,975.25* | ||
| Advertising and marketing expenses | 6,442 | 1,114.5* | ||
| Professional fees | 191,182 | 80,108.5* | ||
| Compensation and related benefits | 272,985 | 1,374,499.5* | ||
| Other general and administrative expenses | 34,899 | 32,765* | ||
| Total operating expenses | 562,655 | 1,602,462.75 | ||
| Loss from operations | -562,655 | -1,602,462.75* | ||
| Interest expense - related parties | 15,025 | 14,953* | ||
| Net gain on settlement of accounts payable | - | 3,405.5* | ||
| Gain on extinguishment of notes payable | - | 216,750* | ||
| Other income | 1,400 | - | ||
| Total other expense, net | -13,625 | 205,202.5* | ||
| Loss before income taxes | -576,280 | -1,397,260.25 | ||
| Net loss | -576,280 | -1,397,260.25 | ||
| Basic EPS | -0.02 | - | ||
| Diluted EPS | -0.02 | -0.054 | ||
| Basic Average Shares | 32,762,434 | - | ||
| Diluted Average Shares | 32,762,434 | 25,695,496 | ||
Genvor Inc (GNVR)
Genvor Inc (GNVR)